Antimicrobial Agents and Chemotherapy · 2020 · 35 citations · 18 references
PharmacyPharmacokineticsPharmacologyAntimicrobial PharmacotherapyAntimicrobial ResistanceClinical PharmacologyAntibacterial PharmacotherapyAntibacterial TherapyAntibiotic ResistanceAntimicrobial TherapyBeta-lactam ResistanceCombination Antimicrobial TherapyBacterial Pneumonia TreatmentBeta-lactamase InhibitorsBroad-spectrum AntimicrobialsMultidrug-resistant OrganismsMultidrug-resistant PathogensNosocomial PneumoniaPneumonia Antibiotic TherapyPneumonia Empiric Therapy
Cefepime-enmetazobactam is a novel β-lactam–β-lactamase inhibitor combination with broad-spectrum antimicrobial activity against a range of multidrug-resistant Enterobacteriaceae . This agent is being developed for a range of serious hospital infections. An understanding of the extent of partitioning of β-lactam–β-lactamase inhibitor combinations into the human lung is required to better understand the potential role of cefepime-enmetazobactam for the treatment of nosocomial pneumonia.
18
Patrick N. A. Harris, Paul Anantharajah Tambyah, David Chien Lye et al. · JAMA · 2018 · 770 citations · Full text
Michael Neely, Michael G. van Guilder, Walter M. Yamada et al. · Therapeutic Drug Monitoring · 2012 · 474 citations · Full text
Marin H. Kollef, Martin Nováček, Ülo Kivistik et al. · The Lancet Infectious Diseases · 2019 · 346 citations